| 1 |
Zhang Q, Wu R, Tan Y, Huang J, Luo S. Novel polymorphism of IFI44L associated with the susceptibility and clinical characteristics of systemic lupus erythematosus in a Chinese population. Int Immunopharmacol 2023;117:109979. [PMID: 36893516 DOI: 10.1016/j.intimp.2023.109979] [Reference Citation Analysis]
|
| 2 |
Cambier S, Gouwy M, Proost P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell Mol Immunol 2023;20:217-51. [PMID: 36725964 DOI: 10.1038/s41423-023-00974-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Ewunkem AJ, Deve M, Harrison SH, Muganda PM. Diepoxybutane induces the p53-dependent transactivation of the CCL4 gene that mediates apoptosis in exposed human lymphoblasts. J Biochem Mol Toxicol 2023;:e23316. [PMID: 36775894 DOI: 10.1002/jbt.23316] [Reference Citation Analysis]
|
| 4 |
Ermakov EA, Mednova IA, Boiko AS, Buneva VN, Ivanova SA. Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review. Int J Mol Sci 2023;24. [PMID: 36768537 DOI: 10.3390/ijms24032215] [Reference Citation Analysis]
|
| 5 |
Melamud MM, Ermakov EA, Boiko AS, Kamaeva DA, Sizikov AE, Ivanova SA, Baulina NM, Favorova OO, Nevinsky GA, Buneva VN. Multiplex Analysis of Serum Cytokine Profiles in Systemic Lupus Erythematosus and Multiple Sclerosis. Int J Mol Sci 2022;23. [PMID: 36430309 DOI: 10.3390/ijms232213829] [Reference Citation Analysis]
|
| 6 |
Fan X, Ng CT, Guo D, Lim F, Tan JC, Law A, Goh LH, Poon ZY, Cheung A, Kong SL, Tan M, Li S, Loh A, James A, Lim T, Chen J, Thumboo J, Hwang W, Low A. Dampened Inflammation and Improved Survival After CXCL5 Administration in Murine Lupus via Myeloid and Neutrophil Pathways. Arthritis Rheumatol 2022. [PMID: 36240108 DOI: 10.1002/art.42383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Mizrachi M, Anderson E, Carroll KR, Tehrani N, Volpe BT, Diamond B. Cognitive dysfunction in SLE: An understudied clinical manifestation. J Autoimmun 2022;:102911. [PMID: 36127204 DOI: 10.1016/j.jaut.2022.102911] [Reference Citation Analysis]
|
| 8 |
Espinosa-Bautista F, Coronel D, Ramos-Rosillo V, Amezcua-Guerra LM. Performance analysis of Luminex and ELISA to profile serum IP-10 as a biomarker in systemic lupus erythematosus. Lupus 2022;:9612033221122978. [PMID: 36040216 DOI: 10.1177/09612033221122978] [Reference Citation Analysis]
|
| 9 |
Wakiya R, Ueeda K, Nakashima S, Shimada H, Kameda T, Mansour MMF, Kato M, Miyagi T, Sugihara K, Mizusaki M, Mino R, Kadowaki N, Dobashi H. Effect of add-on hydroxychloroquine therapy on serum proinflammatory cytokine levels in patients with systemic lupus erythematosus. Sci Rep 2022;12:10175. [PMID: 35715525 DOI: 10.1038/s41598-022-14571-6] [Reference Citation Analysis]
|
| 10 |
Qijiao W, Zhihan C, Makota P, Qing Y, Fei G, Zhihong W, He L. Glomerular Expression of S100A8 in Lupus Nephritis: An Integrated Bioinformatics Analysis. Front Immunol 2022;13:843576. [PMID: 35572531 DOI: 10.3389/fimmu.2022.843576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Chen F, Meng J, Yan W, Wang M, Jiang Y, Gao J. Identification of Novel Immune Cell-Relevant Therapeutic Targets and Validation of Roles of TK1 in BMSCs of Systemic Lupus Erythematosus. Front Mol Biosci 2022;9:848463. [DOI: 10.3389/fmolb.2022.848463] [Reference Citation Analysis]
|
| 12 |
Uprety LP, Park YH, Jang Y. Autoantigen spermatid nuclear transition protein 1 enhances pro-inflammatory cytokine production stimulated by anti-DNA autoantibodies in macrophages. Eur J Inflamm 2022;20:1721727X2211317. [DOI: 10.1177/1721727x221131792] [Reference Citation Analysis]
|
